Transition in Glycogen Storage Disease type 2 (GSD2): state of art in Italian Centers
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingSGLT2 inhibitors improve skeletal muscle impairment in an animal model of heart failure by modulating glucose and ion homeostasis
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingA case of Spinal Muscular Atrophy with genetic susceptibility for thrombotic microangiopathies
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingAxial involvement in Facioscapulohumeral dystrophy (FSHD): imaging and clinical features.
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingDifferential exon usage predicts disease course in the wide titinopathy spectrum
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingEnhancing FSHD Diagnosis: a one-year follow-up study on the Efficacy of a Combined Methylation Assay and Machine Learning Pipeline
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingDiaphragmatic Ultrasonography in the respiratory assessment of Facioscapulohumeral Muscular Dystrophy (FSHD): a promising approach for management and longitudinal follow-up
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingA Real-life experience with Eculizumab and Efgartigimod in generalized Myasthenia Gravis patients
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingLongitudinal echocardiographic measures in Becker muscular dystrophy
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingSEGRETERIA NAZIONALE AIM
Seguici sulle nostre pagine social
SEGRETERIA ORGANIZZATIVA FIRST CLASS
First Class S.r.l. Meetings and Conferences